| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000021499 |
| Receipt No. | R000024795 |
| Official scientific title of the study | Research for cryopreservation and reuse of ovarian tissue and oocytes using ovaries obtained from gender identity disorder patients |
| Date of disclosure of the study information | 2016/03/16 |
| Last modified on | 2018/03/19 (Ver. 3) |
| Basic information | |||
| Official scientific title of the study | Research for cryopreservation and reuse of ovarian tissue and oocytes using ovaries obtained from gender identity disorder patients | ||
| Title of the study (Brief title) | Research for cryopreservation and reuse of ovarian tissue and oocytes using ovaries obtained from gender identity disorder patients | ||
| Region |
|
||
| Condition | |||
| Condition | gender identity disorder | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Establishment of cryopreservation and reuse of ovarian tissue and oocytes and its application to infertility and fertility preservation of cancer patients |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | viability of transplanted ovarian tissue |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Gender identity disorder patients who undergo sex reassignment surgery (hysterectomy and oophorectomy) and provide informed consent to the present research | |||
| Key exclusion criteria | Gender identity disorder patients who do not provide informed consent to the research or for whom sex reassignment surgery is contraindicated | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yasushi Takai |
| Organization | Saitama Medical Center/ Saitama Medical University |
| Division name | Department of Obstetrics and Gynecology |
| Address | 1981 Kamoda, Kawagoe, Saitama, Japan |
| TEL | 049-228-3681 |
| yastakai@saitama-med.ac.jp | |
| Public contact | |
| Name of contact person | Yasushi Takai |
| Organization | Saitama Medical Center/ Saitama Medical University |
| Division name | Department of Obstetrics and Gynecology |
| Address | 1981 Kamoda, Kawagoe, Saitama, Japan |
| TEL | 049-228-3681 |
| Homepage URL | |
| yastakai@saitama-med.ac.jp | |
| Sponsor | |
| Institute | Saitama Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grants-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Cohort study for GID patients who visit our clinic between May 1, 2011 and March 31, 2016 and are eligible for our study protocol.
Ovarian tissue and oocytes obtained by sex reassignment surgery are cryopreserved. Cryopreserved ovarian tissue are thawed and transplanted to immunodeficient mice, and survival rate of oocytes is evaluated. Oogonial stem cells are extracted from cryopreserved ovarian tissue, and utilized for oocyte survival in the transplanted tissue. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024795 |